D1000 Varejo earnings calendar shapes up, Brazilian pharmacy stock on watch

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-25, 22:18.

D1000 Varejo Farma (BRDMVFACNOR3) operates a chain of drugstores and pharmacies in Brazil and publishes its financial statements and calendar via the B3 exchange and its own investor-relations pages. The next detailed earnings updates and corporate events matter for investors comparing the stock with Brazilian peer Raia Drogasil on B3.

Upcoming dates and reporting rhythm

D1000 Varejo Farma reports its results and other material information under Brazilian corporate law via the B3 exchange and the CVM system, with English summaries on its investor-relations website. The company aligns its disclosure rhythm with typical quarterly and annual reporting cycles for Brazilian listed retailers. The investor-relations section outlines financial statements, presentations and calendar.

As with many Brazilian mid-cap retailers on B3, earnings releases typically cluster around March for full-year numbers and roughly May, August and November for subsequent quarterly updates, though exact dates can vary year by year and are confirmed closer to publication. Investors following D1000 Varejo Farma therefore monitor both the company IR page and the official B3 announcements feed to capture precise dates and accompanying conference calls.

What analysts and peers signal

Coverage of Brazilian pharmacy and drugstore operators often centers on larger peers such as Raia Drogasil or Pague Menos, whose analyst calls and target price revisions provide a reference frame for smaller chains like D1000 Varejo Farma. These larger retailers are followed by international houses including Goldman Sachs, Morgan Stanley and UBS, which address themes such as consumer demand, same-store sales trends and competitive intensity in Brazilian healthcare retail. Reuters analyst coverage of Raia Drogasil offers a benchmark for sector expectations.

For D1000 Varejo Farma, consensus data and detailed analyst numbers are less widely disseminated internationally than for blue-chip peers, a common pattern for smaller B3 listings. Nevertheless, Brazilian brokerage reports and local research often assess profitability metrics such as EBITDA margins, net income trends and leverage, with investors comparing these figures against sector averages for pharmacy and drugstore chains in Brazil.

How D1000 Varejo Farma makes its money

D1000 Varejo Farma generates revenue primarily from operating retail pharmacies and drugstores in Brazil, selling prescription medicines, over-the-counter drugs, personal care items and related health products. The company uses its store network and local brand positioning to compete with other Brazilian chains and regional independents.

Where the stock trades today

D1000 Varejo Farma shares trade on the B3 exchange in Sao Paulo under the local Brazilian listing, quoted in Brazilian real (BRL); detailed, time-stamped price data and recent volumes are available directly on the B3 website and major financial data platforms.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.